They bet on AI before others did. Now they have the first computer-designed vaccine that passed human trials.

▤ Summary

A Cambridge spin-off has advanced a vaccine designed by AI into human testing for the first time. The approach uses machine learning to identify stable parts of virus families so the vaccine can protect against multiple strains at once, even those that have not yet emerged. Early results from a small safety trial in 39 people show the vaccine appears safe and triggered an immune response. The team is also testing related vaccines for seasonal flu, bird flu, and viral hemorrhagic fevers. This could speed vaccine development and create a new model for broader, more durable immunization programs.

▦ Linked Companies